Xia Yu's Form 4 filing
Summit Therapeutics Inc. (SMMT) · filed Oct 23, 2025
- Accession no.
- 0001963544-25-000004
- Filed
- Oct 23, 2025
- Trade date
- Oct 21, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $10.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Xia YuCIK 0001963544 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 21, 2025 | Common Stock | PPurchaseAcquired | +533,617 | $18.74 | +$9,999,982.58 | 32,057,147 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.